Evidence map›Paper›PMID 33639375›Full record

ArticleDiagnostic microbiology and infectious disease2021

Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection.

F Cogliati Dezza, A Oliva, F Cancelli, G Savelloni, S Valeri, V Mauro, M Calabretto, G Russo, M Venditti, O Turriziani and 1 more

Abstract read
In one paragraph

Article in Diagnostic microbiology and infectious disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

F Cogliati DezzaDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
A OlivaDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy. Electronic address: alessandra.oliva@uniroma1.it.
F CancelliDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
G SavelloniDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
S ValeriDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
V MauroDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
M CalabrettoMicrobiology and Virology Laboratory, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
G RussoDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
M VendittiDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
O TurrizianiMicrobiology and Virology Laboratory, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
C M MastroianniDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection. MATERIALS AND

methodsHospitalized patients with SARS-CoV-2 positive nasopharyngeal RT-PCR were included in a single-center, retrospective study. Patients were divided in 2 groups according to the timing of viral clearance [≤14 days, "early clearance (EC)" and >14 days, "late clearance (LC)"].

results179 patients were included in the study (101 EC, 78 LC), with median age 62 years. Median time of viral shedding was 14 days (EC/LC 10 and 19 days, respectively, P < 0.0001). Univariate analyses showed that age, male gender, receiving corticosteroids, receiving tocilizumab, ICU admission, low albumin and NLR ratio were associated with late viral clearance. In the multivariable analysis, older age (P = 0.016), albumin level (P = 0.048), corticosteroids (P = 0.021), and tocilizumab (P = 0.015) were significantly associated with late viral clearance.

conclusionsAge, albumin, tocilizumab and corticosteroid treatment were independently associated with a prolonged SARS-CoV-2 RNA shedding.

Indexed as

Virus SheddingAgedCOVID-19FemaleHospitalizationHumansMaleMiddle AgedRetrospective StudiesRisk FactorsRNA, ViralSARS-CoV-2Time FactorsRNA, ViralICU admissionSARS-CoV-2steroidstocilizumabViral shedding

Identifiers

PMID33639375
PMCPMC7879029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.